About New York University Langone Medical Center: Department of Medicine, Division of Rheumatology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at New York University Langone Medical Center: Department of Medicine, Division of Rheumatology
During the past decade, New York University Langone Medical Center: Department of Medicine, Division of Rheumatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "New York University Langone Medical Center: Department of Medicine, Division of Rheumatology"
#1 collaborator was "Autoimmunity Centers of Excellence" with 2 trials as a collaborator, "Rho Federal Systems Division, Inc." with 2 trials as a collaborator and "Corbus Pharmaceuticals Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at New York University Langone Medical Center: Department of Medicine, Division of Rheumatology
According to Clinical.Site data, the most researched conditions in "New York University Langone Medical Center: Department of Medicine, Division of Rheumatology" are
"Juvenile Dermatomyositis (JDM)" (1 trials), "Juvenile Idiopathic Arthritis (JIA)" (1 trials), "Lupus" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Pediatric SLE" (1 trials). Many other conditions were trialed in "New York University Langone Medical Center: Department of Medicine, Division of Rheumatology" in a lesser frequency.
Clinical Trials Intervention Types at New York University Langone Medical Center: Department of Medicine, Division of Rheumatology
Most popular intervention types in "New York University Langone Medical Center: Department of Medicine, Division of Rheumatology" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ad26.COV2.S" (1 trials), "BNT162b2" (1 trials), "BNT162b2, Bivalent" (1 trials), "Continue IS (B cell depletion therapy)" (1 trials) and "Continue IS (MMF or MPA)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at New York University Langone Medical Center: Department of Medicine, Division of Rheumatology
The vast majority of trials in "New York University Langone Medical Center: Department of Medicine, Division of Rheumatology" are
2 trials for "All" genders.
Clinical Trials Status at New York University Langone Medical Center: Department of Medicine, Division of Rheumatology
Currently, there are NaN active trials in "New York University Langone Medical Center: Department of Medicine, Division of Rheumatology".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in New York University Langone Medical Center: Department of Medicine, Division of Rheumatology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in New York University Langone Medical Center: Department of Medicine, Division of Rheumatology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".